Compare JZ & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JZ | EDVA |
|---|---|---|
| Founded | 2011 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Beverages (Production/Distribution) |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 1.2M |
| IPO Year | 2021 | 2012 |
| Metric | JZ | EDVA |
|---|---|---|
| Price | $1.38 | $0.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 17.4M | 1.8M |
| Earning Date | 10-27-2026 | 11-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,066.00 |
| Revenue This Year | N/A | $24,377.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.09 | $0.14 |
| 52 Week High | $5.46 | $0.33 |
| Indicator | JZ | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 66.65 | 21.54 |
| Support Level | $0.67 | N/A |
| Resistance Level | $1.51 | $0.18 |
| Average True Range (ATR) | 0.23 | 0.02 |
| MACD | 0.15 | -0.00 |
| Stochastic Oscillator | 77.18 | 14.26 |
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has single operating segment: Educational content services and other services and IT-related solution services.
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.